AIDS research. FDA panel recommends anti-HIV drug for prevention.

Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication Model: Print Cited Medium: Internet ISSN: 1095-9203 (Electronic) Linking ISSN: 00368075 NLM ISO Abbreviation: Science Subsets: MEDLINE

Publication: : Washington, DC : American Association for the Advancement of Science
Original Publication: New York, N.Y. : [s.n.] 1880-

Drug Approval* ; United States Food and Drug Administration*; Anti-HIV Agents/*therapeutic use ; Deoxycytidine/*analogs & derivatives ; HIV Infections/*prevention & control ; Organophosphorus Compounds/*therapeutic use; Advisory Committees ; Deoxycytidine/therapeutic use ; Drug Combinations ; Drug Resistance, Viral ; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination ; Female ; HIV/drug effects ; HIV Infections/transmission ; Humans ; Male ; Medication Adherence ; Risk-Taking ; United States

0 (Anti-HIV Agents)
0 (Drug Combinations)
0 (Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination)
0 (Organophosphorus Compounds)
0W860991D6 (Deoxycytidine)

Date Created: 20120519 Date Completed: 20120529 Latest Revision: 20151119

20240628

10.1126/science.336.6083.792

22605725